Synthesis and evaluation of a multifunctional probe with a high affinity for prostate-specific membrane antigen (PSMA) and bone.

Prostate cancer frequently metastasizes to the bone. Because patients with bone metastases suffer from skeletal-related events, the diagnosis and treatment of bone metastases in the early stage are important. In this study, to improve the sensitivity of detecting bone metastases in patients with prostate cancer, we designed, synthesized, and evaluated a multifunctional radiotracer, [ ⁶⁷ Ga]Ga-D ₁₁ -PSMA-617 ([ ⁶⁷ Ga]3), with an undeca-aspartic acid as a bone-seeking moiety between [ ⁶⁷ Ga]Ga-DOTA and a prostate-specific membrane antigen (PSMA) ligand based on the lysine-urea-glutamate motif. [ ⁶⁷ Ga]3 showed a high affinity for hydroxyapatite and high uptake in PSMA-positive LNCaP cells. Moreover, in biodistribution experiments using tumor-bearing mice, [ ⁶⁷ Ga]3 exhibited high accumulation in the bone and PSMA-positive tumor although the accumulation of [ ⁶⁷ Ga]3 in the PSMA-positive tumor was lower than that of [ ⁶⁷ Ga]Ga-PSMA-617. This study provides valuable information for developing radiotheranostic probes combining multiple carriers with different mechanisms.
(Copyright © 2022 Elsevier Inc. All rights reserved.)